Cancer vaccines at the age of immune checkpoint inhibitors: reasonable approach as combination therapy in advanced urothelial carcinoma?
Department of Hematology & Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland.
P
P
Grivas
Department of Hematology & Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland.
V S
VS
Koshkin
Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA.
S K
SK
Pal
D019496:Cancer Vaccines; D002295:Carcinoma, Transitional Cell; D006801:Humans; D014571:Urologic Neoplasms
D019496:Cancer Vaccines